Numerous investigations mentioned high mutation rate of BRAF gene in various thyroid carcinomas [19–22], wherein T1799A nucleotide transversion is the most common oncogenic mutation of BRAF gene. This evidence concerns the gene BRAF and thyroid gland carcinoma.